SMITH TODD N 4
4 · Zyla Life Sciences · Filed Mar 5, 2020
Insider Transaction Report
Form 4
SMITH TODD N
DirectorPresident and CEO
Transactions
- Award
Common Stock
2020-03-04+165,500→ 165,500 total - Award
Stock Option (right to buy)
2020-03-04+241,500→ 241,500 totalExercise: $1.50Exp: 2030-03-04→ Common Stock (241,500 underlying)
Footnotes (2)
- [F1]Represents non-qualified stock option, 1/3 of which vests on the first anniversary of the grant date and 1/36 of which vests each month thereafter until the option is 100% vested.
- [F2]Represents restricted stock units, which vest in three equal annual installments on the first three anniversaries of the date of grant.